Environmentally friendly GM tomatoes
Nature Biotechnology pp 870 - 875 and pp 826 - 827
Medicinal fruits produced through genetic engineering could facilitate administration of medicines and lower their cost as well, especially in developing countries. But there are concerns as to the environmental hazards resulting from transgene transfer from GM crops to weeds. Now, a team of plant scientists in Germany and Brazil are closer to the goal of a safer GM crop that could be used to produce medicinals. Rather than transforming the chromosomes of the plant cell nucleus, they have targeted the circular DNA genome of tomato chloroplasts, the structures that generate energy from sunlight in plant cells.
Plants engineered by nuclear transformation often express only low amounts of a foreign protein and suffer the drawback that windborne pollen can spread the transgene to neighboring plants, raising containment concerns. For these and other reasons, several research groups have focused on subcellular structures called plastids (e.g., chloroplasts and chromoplasts), tiny granules that inhabit every cell of higher plants. Each cell can contain thousands of copies of each plastid genome, meaning that transformation leads to hyperexpression of the desired protein. Yet plastid DNA is generally not transmitted in pollen, lessening the chance of unwanted spread. Until now, though, chloroplast transformation has been achieved routine only in tobacco; other plants have been sterile and/or shown disappointing expression levels in nonleafy tissues.
By especially refining the circle of foreign DNA used for chloroplast transformation and making a few changes in tissue culture technique, Ralph Bock and colleagues cultivated fertile transplastomic tomatoes loaded with the desired protein. This system could potentially facilitate the delivery of vaccines, drugs, and antibodies in edible tomatoes.